2-[[2-(benzotriazol-1-yl)acetyl]-[(3-chloro-5-fluorophenyl)methyl]amino]-5-(1H-imidazol-5-yl)benzoic acid
C25H18ClFN6O3 — CID 171770295
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[2-(benzotriazol-1-yl)acetyl]-[(3-chloro-5-fluorophenyl)methyl]amino]-5-(1H-imidazol-5-yl)benzoic acid
2-[[2-(benzotriazol-1-yl)acetyl]-[(3-chloro-5-fluorophenyl)methyl]amino]-5-(1H-imidazol-5-yl)benzoic acid (PubChem CID 171770295) has the molecular formula C25H18ClFN6O3 and a molecular weight of 504.91 g/mol. Its IUPAC name is 2-[[2-(benzotriazol-1-yl)acetyl]-[(3-chloro-5-fluorophenyl)methyl]amino]-5-(1H-imidazol-5-yl)benzoic acid.
Molecular Properties
| Compound Name | 2-[[2-(benzotriazol-1-yl)acetyl]-[(3-chloro-5-fluorophenyl)methyl]amino]-5-(1H-imidazol-5-yl)benzoic acid |
|---|---|
| PubChem CID | 171770295 |
| Molecular Formula | C25H18ClFN6O3 |
| Molecular Weight | 504.91 g/mol |
| Exact Mass | 504.11 |
| IUPAC Name | 2-[[2-(benzotriazol-1-yl)acetyl]-[(3-chloro-5-fluorophenyl)methyl]amino]-5-(1H-imidazol-5-yl)benzoic acid |
| SMILES | O=C(O)c1cc(-c2cnc[nH]2)ccc1N(Cc1cc(F)cc(Cl)c1)C(=O)Cn1nnc2ccccc21 |
| InChI | InChI=1S/C25H18ClFN6O3/c26-17-7-15(8-18(27)10-17)12-32(24(34)13-33-23-4-2-1-3-20(23)30-31-33)22-6-5-16(9-19(22)25(35)36)21-11-28-14-29-21/h1-11,14H,12-13H2,(H,28,29)(H,35,36) |
| InChIKey | FEVOFABPFBFMDL-UHFFFAOYSA-N |
| XLogP | 4.55 |
| TPSA | 117.00 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 504.91 |
| LogP ≤ 5 | 4.55 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171770295 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.